The Tennessee Sickle Cell Disease Surveillance Program
Our Mission
“Our mission is to enhance the quality of life for individuals affected by Sickle Cell Disease through focused data collection, analysis, and targeted public health initiatives.”
“A robust disease surveillance program is an essential part of a public health approach to improving outcomes for the sickle cell community by identifying and monitoring geographical discrepancies and incongruities in care provision and providing opportunities for tracking the impact of important disease-modifying therapies.“
SCDC of Tennessee
Welcome to the Tennessee Sickle Cell Disease Surveillance Program website. Our mission is to enhance the quality of life for individuals affected by sickle cell disease (SCD) through data collection, analysis, and targeted public health initiatives. Given the high prevalence of SCD in Tennessee, we aim to provide comprehensive, high-quality data to educate the public and offer valuable resources to the sickle cell community.
Explore our website to hear personal stories from sickle cell Warriors and discover a wealth of resources for those affected by SCD. Click “More About Us” below to access detailed data and learn about the history of our program.
Thank you for visiting and supporting our efforts to combat sickle cell disease in Tennessee. Together, we can make a significant difference in the lives of those living with sickle cell disease.
The Warrior Experience
A Caregiver's Role
When Vera learned her son, Joshua, had a form of sickle cell disease (SCD), she didn’t realize how serious his condition was. As Joshua grew up, Vera and her family learned that SCD is serious and began searching for a possible bone marrow donor for him. Follow the link to read more (Read Here).
Living With Sickle Cell
Follow the link to read personal stories about sickle cell disease and sickle cell trait (Read Here).
Relationships & Friendships
Anxiety, Stress, and Depression
A Powerful Firsthand Story From a Sickle Cell Warrior—Tabatha J Marmon (Read Here)